Aquaculture Therapeutics Market

Aquaculture Therapeutics Market by Products (Formalin Solution, Chorionic Gonadotropin, Florfenicol, Tricaine Methane Sulfonate, Oxytetracycline, and Hydrogen Peroxide), End-users (E-commerce and Veterinary Pharmacies), Environment (Fresh Water, Marine Water, and Brackish Water), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028.

  • Report ID: HC-2328
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 144
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global aquaculture therapeutics market size is anticipated to expand at a significant CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the rising prevalence of diseases, advancements in research on the aquaculture, and growing demand of aquatic animals for nutrition.

Aquaculture Therapeutics Market Key Takeaways

The farming or culturing of aquatic animals such as the algae, crustaceans, aquatic plants, fishes, mollusks, and other aquatic organisms in several types of water is called as Aquaculture. The process includes cultivation of these aquatic organism in the regulated atmospherically conditions either in salt or in fresh water. These organisms are then collected to be used as the source of therapeutic ingredients or as a source of nutrition. The aquatic organisms are highly sensitive to several prevalent diseases. The factors that affect aquatic animals are pathogens such as bacteria, fungi viruses, and parasites that are present in all natural water bodies. These wounds or infection of aqua animals such as fish can be treated with the use of different antibiotics as well as other medicines, which are mostly approved by the US Food and Drug Administration (FDA). Some of the common components used for drugs are tricaine methane sulfonate, chorionic gonadotropin, calcium chloride, formalin solution, papain, carbon dioxide gas, magnesium sulfate, hydrogen peroxide, sodium bicarbonate, acetic acid, calcium oxide, potassium chloride, sodium chloride, urea, and tannic acid. The aqua-based drugs prevent the aquatic animals from deadliest diseases and keep them healthy.

The COVID-19 pandemic has widely impacted the world business negatively. The pandemic had adversely affected the aquaculture therapeutics market as the world witnessed lockdowns, restrictions, and surge in the COVID-19 cases. This increased the burden on healthcare services due to which the focus on other non-COVID healthcare related-sectors were substantially reduced.

Market Trends, Drivers, Restraints, and Opportunities

  • Large number of research activities in the aquaculture and increase in the drug approvals of therapeutic products of aquatic animals are driving the market growth.
  • Rising demand for advanced aquaculture therapeutics due to increasing focus for aqua farming practices globally is propelling the market growth during the forecast period.
  • Increasing number of global consumption of fishes and expansion of fish farming for commercial purposes is boosting the market growth.
  • Less awareness among the population regarding the health of the aquatic animals and high cost of the aquatic animal farming are proving to be key restraints to the market.
  • High prevalence of disease among aquatic animals, rising research & development activities in the field, and high demand of aquatic animals are offering huge opportunities for the market expansion in the near future.

Scope of the Report

The report on the global aquaculture therapeutics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Aquaculture Therapeutics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Formalin Solution, Chorionic Gonadotropin, Florfenicol, Tricaine Methane Sulfonate, Oxytetracycline, and Hydrogen Peroxide), End-users (E-commerce and Veterinary Pharmacies), and Environment (Fresh Water, Marine Water, and Brackish Water)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

TunaTech GmbH; Unima Group; ViAqua Therapeutics Ltd; Alpharma Inc.; Sea Watch International Ltd.; Blue Ridge Aquaculture; Cermaq ASA; Cooke Aquaculture; Nireus S.A.; Nutreco Holding N.V.; Kona Bay Marine Resources; Royal Greenland; Selonda Aquaculture S.A.; StarKist Taylor Shellfish Inc.; Nireus Aquaculture S.A and Tassal group Ltd.; and TriMarine International and Seafood Company

Market Segment Insights

Oxytetracycline segment is expected to grow at a rapid pace

Based on products, the global aquaculture therapeutics market is segmented into formalin solution, florfenicol, chorionic gonadotropin, oxytetracycline, tricaine methane sulfonate, and hydrogen peroxide. The oxytetracycline segment is expected to grow at a significant rate in the coming years as it is highly recommended and preferred by the doctors and professionals. Moreover, it shows considerable effect for the treatment of infections on the aquatic animals. These products are used to maintain and cure the diseases of the aquatic animals.

Aquaculture Therapeutics Market By Products

Veterinary pharmacies segment is projected to expand at a considerable CAGR

On the basis of end-users, the market is bifurcated into e-commerce and veterinary pharmacies. The veterinary pharmacies segment is projected to expand at a considerable CAGR during the forecast period owing to the easy availability and wide presence of these pharmacies around the globe. However, the e-commerce segment is anticipated to propel at a substantial growth rate during the forecast period due to the easy access of internet to the population and cheap medicines on this platform.

Fresh water segment is anticipated to dominate the market

Based on the environment, the global aquaculture therapeutics market is divided into marine water, fresh water, and brackish water. The fresh water segment is anticipated to dominate the market since fishes are widely nurtured and adopted for farming using the fresh water and are less likely to get infections or diseases. The other factor driving this segment is decline in the fish population in oceans globally.

North America is anticipated to constitute a key market share

In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to hold a key market share during the targeted period as the region has advanced healthcare therapeutics system as well as the significant awareness of region’s population regarding the aquaculture therapeutics. Additionally, government initiatives to create awareness and promote aquaculture therapeutics is boosting the regional market expansion during the projected period.

The Asia Pacific market, however, is estimated to exhibit substantial growth in the near future owing to the high population of aquatic life in the region and variety of organisms with high prevalence of diseases in many parts of the region.

Aquaculture Therapeutics Market By Regions

Segments

Segments Covered in the Report
The global aquaculture therapeutics market has been segmented on the basis of

Products
  • Formalin Solution
  • Chorionic Gonadotropin
  • Florfenicol
  • Tricaine Methane Sulfonate
  • Oxytetracycline
  • Hydrogen Peroxide
End-users
  • E-commerce
  • Veterinary Pharmacies
Environment
  • Fresh Water
  • Marine Water
  • Brackish Water
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • TunaTech GmbH
  • Unima Group
  • ViAqua Therapeutics Ltd
  • Alpharma Inc.
  • Sea Watch International Ltd
  • Blue Ridge Aquaculture
  • Cermaq ASA
  • Cooke Aquaculture
  • Nireus S.A.
  • Nutreco Holding N.V.
  • Kona Bay Marine Resources
  • Royal Greenland
  • Selonda Aquaculture S.A.
  • StarKist Taylor Shellfish Inc.
  • Nireus Aquaculture S.A and Tassal group Ltd.
  • TriMarine International and Seafood Company

Competitive Landscape

Key players competing in the global aquaculture therapeutics market are TunaTech GmbH; Unima Group; Nutreco Holding N.V.; ViAqua Therapeutics Ltd; Alpharma Inc.; Sea Watch International Ltd.; Blue Ridge Aquaculture; Cooke Aquaculture; Nireus S.A.; Kona Bay Marine Resources; Royal Greenland; Selonda Aquaculture S.A.; StarKist Taylor Shellfish Inc.; Nireus Aquaculture S.A and Tassal group Ltd.; TriMarine International and Seafood Company; and Cermaq ASA.

Aquaculture Therapeutics Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Aquaculture Therapeutics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Aquaculture Therapeutics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Aquaculture Therapeutics Market - Supply Chain
  4.5. Global Aquaculture Therapeutics Market Forecast
     4.5.1. Aquaculture Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Aquaculture Therapeutics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Aquaculture Therapeutics Market Absolute $ Opportunity
5. Global Aquaculture Therapeutics Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Aquaculture Therapeutics Market Size and Volume Forecast by End Users
     5.3.1. E-commerce Veterinary Pharmacies
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Aquaculture Therapeutics Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Aquaculture Therapeutics Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Aquaculture Therapeutics Demand Share Forecast, 2019-2026
7. North America Aquaculture Therapeutics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Aquaculture Therapeutics Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Aquaculture Therapeutics Market Size and Volume Forecast by End Users
     7.4.1. E-commerce Veterinary Pharmacies
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Aquaculture Therapeutics Demand Share Forecast, 2019-2026
8. Latin America Aquaculture Therapeutics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Aquaculture Therapeutics Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Aquaculture Therapeutics Market Size and Volume Forecast by End Users
     8.4.1. E-commerce Veterinary Pharmacies
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Aquaculture Therapeutics Demand Share Forecast, 2019-2026
9. Europe Aquaculture Therapeutics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Aquaculture Therapeutics Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Aquaculture Therapeutics Market Size and Volume Forecast by End Users
     9.4.1. E-commerce Veterinary Pharmacies
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Aquaculture Therapeutics Demand Share Forecast, 2019-2026
10. Asia Pacific Aquaculture Therapeutics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Aquaculture Therapeutics Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Aquaculture Therapeutics Market Size and Volume Forecast by End Users
     10.4.1. E-commerce Veterinary Pharmacies
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Aquaculture Therapeutics Demand Share Forecast, 2019-2026
11. Middle East & Africa Aquaculture Therapeutics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Aquaculture Therapeutics Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Aquaculture Therapeutics Market Size and Volume Forecast by End Users
     11.4.1. E-commerce Veterinary Pharmacies
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Aquaculture Therapeutics Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Aquaculture Therapeutics Market: Market Share Analysis
  12.2. Aquaculture Therapeutics Distributors and Customers
  12.3. Aquaculture Therapeutics Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. TunaTech GmbH Unima Group ViAqua Therapeutics Ltd  
Segments Covered in the Report
The global aquaculture therapeutics market has been segmented on the basis of

Products
  • Formalin Solution
  • Chorionic Gonadotropin
  • Florfenicol
  • Tricaine Methane Sulfonate
  • Oxytetracycline
  • Hydrogen Peroxide
End-users
  • E-commerce
  • Veterinary Pharmacies
Environment
  • Fresh Water
  • Marine Water
  • Brackish Water
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • TunaTech GmbH
  • Unima Group
  • ViAqua Therapeutics Ltd
  • Alpharma Inc.
  • Sea Watch International Ltd
  • Blue Ridge Aquaculture
  • Cermaq ASA
  • Cooke Aquaculture
  • Nireus S.A.
  • Nutreco Holding N.V.
  • Kona Bay Marine Resources
  • Royal Greenland
  • Selonda Aquaculture S.A.
  • StarKist Taylor Shellfish Inc.
  • Nireus Aquaculture S.A and Tassal group Ltd.
  • TriMarine International and Seafood Company

Key players competing in the global aquaculture therapeutics market are TunaTech GmbH; Unima Group; Nutreco Holding N.V.; ViAqua Therapeutics Ltd; Alpharma Inc.; Sea Watch International Ltd.; Blue Ridge Aquaculture; Cooke Aquaculture; Nireus S.A.; Kona Bay Marine Resources; Royal Greenland; Selonda Aquaculture S.A.; StarKist Taylor Shellfish Inc.; Nireus Aquaculture S.A and Tassal group Ltd.; TriMarine International and Seafood Company; and Cermaq ASA.

Aquaculture Therapeutics Market By Key Players

Buy Report